In a ceremony with less media fanfare than US patent attorneys might have expected, President Obama signed into law legislation that radically revises US patent law.
A new treatment for prostate cancer launched in the UK this week. The drug was discovered by scientists in London, funded by the public. So why is it owned by a US pharma giant?
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.